254 related articles for article (PubMed ID: 20360846)
1. Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth.
Takeuchi K; Abe M; Hiasa M; Oda A; Amou H; Kido S; Harada T; Tanaka O; Miki H; Nakamura S; Nakano A; Kagawa K; Yata K; Ozaki S; Matsumoto T
PLoS One; 2010 Mar; 5(3):e9870. PubMed ID: 20360846
[TBL] [Abstract][Full Text] [Related]
2. TGF-β-related mechanisms of bone destruction in multiple myeloma.
Matsumoto T; Abe M
Bone; 2011 Jan; 48(1):129-34. PubMed ID: 20570621
[TBL] [Abstract][Full Text] [Related]
3. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.
Kassem M; Kveiborg M; Eriksen EF
Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903
[TBL] [Abstract][Full Text] [Related]
4. Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease.
D'Souza S; del Prete D; Jin S; Sun Q; Huston AJ; Kostov FE; Sammut B; Hong CS; Anderson JL; Patrene KD; Yu S; Velu CS; Xiao G; Grimes HL; Roodman GD; Galson DL
Blood; 2011 Dec; 118(26):6871-80. PubMed ID: 22042697
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms for formation of myeloma bone disease].
Yata K; Abe M; Matsumoto T
Clin Calcium; 2008 Apr; 18(4):438-46. PubMed ID: 18379024
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis.
Karsdal MA; Larsen L; Engsig MT; Lou H; Ferreras M; Lochter A; Delaissé JM; Foged NT
J Biol Chem; 2002 Nov; 277(46):44061-7. PubMed ID: 12226090
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma.
Lu A; Pallero MA; Lei W; Hong H; Yang Y; Suto MJ; Murphy-Ullrich JE
Am J Pathol; 2016 Mar; 186(3):678-90. PubMed ID: 26801735
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.
Nyman JS; Merkel AR; Uppuganti S; Nayak B; Rowland B; Makowski AJ; Oyajobi BO; Sterling JA
Bone; 2016 Oct; 91():81-91. PubMed ID: 27423464
[TBL] [Abstract][Full Text] [Related]
9. The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis.
Gilbert LC; Rubin J; Nanes MS
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1011-8. PubMed ID: 15625085
[TBL] [Abstract][Full Text] [Related]
10. Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites.
Xu X; Zhang C; Trotter TN; Gowda PS; Lu Y; Ponnazhagan S; Javed A; Li J; Yang Y
Cancer Res; 2020 Mar; 80(5):1036-1048. PubMed ID: 31911552
[TBL] [Abstract][Full Text] [Related]
11. Sulfuretin induces osteoblast differentiation through activation of TGF-β signaling.
Song NJ; Kwon SM; Kim S; Yoon HJ; Seo CR; Jang B; Chang SH; Ku JM; Lee JS; Park KM; Hong JW; Kim GH; Park KW
Mol Cell Biochem; 2015 Dec; 410(1-2):55-63. PubMed ID: 26260053
[TBL] [Abstract][Full Text] [Related]
12. TGF-β Signaling Plays an Essential Role in the Lineage Specification of Mesenchymal Stem/Progenitor Cells in Fetal Bone Marrow.
Abou-Ezzi G; Supakorndej T; Zhang J; Anthony B; Krambs J; Celik H; Karpova D; Craft CS; Link DC
Stem Cell Reports; 2019 Jul; 13(1):48-60. PubMed ID: 31204302
[TBL] [Abstract][Full Text] [Related]
13. [Cytokines and myeloma bone disease].
Abe M
Clin Calcium; 2014 Jun; 24(6):871-8. PubMed ID: 24870838
[TBL] [Abstract][Full Text] [Related]
14. Effects of two vitamins, two growth factors and dexamethasone on the proliferation of rat bone marrow stromal cells and osteoblastic MC3T3-E1 cells.
Taira M; Nakao H; Takahashi J; Araki Y
J Oral Rehabil; 2003 Jul; 30(7):697-701. PubMed ID: 12791154
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
[TBL] [Abstract][Full Text] [Related]
16. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
[TBL] [Abstract][Full Text] [Related]
17. Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation.
Giuliani N; Colla S; Morandi F; Lazzaretti M; Sala R; Bonomini S; Grano M; Colucci S; Svaldi M; Rizzoli V
Blood; 2005 Oct; 106(7):2472-83. PubMed ID: 15933061
[TBL] [Abstract][Full Text] [Related]
18. TGF-β inhibits osteogenesis by upregulating the expression of ubiquitin ligase SMURF1 via MAPK-ERK signaling.
Sun X; Xie Z; Ma Y; Pan X; Wang J; Chen Z; Shi P
J Cell Physiol; 2018 Jan; 233(1):596-606. PubMed ID: 28322449
[TBL] [Abstract][Full Text] [Related]
19. Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma.
Hiasa M; Teramachi J; Oda A; Amachi R; Harada T; Nakamura S; Miki H; Fujii S; Kagawa K; Watanabe K; Endo I; Kuroda Y; Yoneda T; Tsuji D; Nakao M; Tanaka E; Hamada K; Sano S; Itoh K; Matsumoto T; Abe M
Leukemia; 2015 Jan; 29(1):207-17. PubMed ID: 24787487
[TBL] [Abstract][Full Text] [Related]
20. TGF-β mediates suppression of adipogenesis by estradiol through connective tissue growth factor induction.
Kumar A; Ruan M; Clifton K; Syed F; Khosla S; Oursler MJ
Endocrinology; 2012 Jan; 153(1):254-63. PubMed ID: 22067314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
